Quick Takeaways
- Ross Haghighat has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,860,906.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Ross Haghighat
- Location
- Berkeley, CA
- Summary
- The estimated net worth of Ross Haghighat is at least $4,860,906 dollars as of 31 May 2023. Ross Haghighat is the Director of CHINOOK THERAPEUTICS, INC. and owns shares of CHINOOK THERAPEUTICS, INC. stock worth about $4.86M.
- Signature
- /s/ Kirk Schumacher, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ross Haghighat and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: CHINOOK THERAPEUTICS, INC. ($4,860,906).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ross Haghighat
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KDNY | CHINOOK THERAPEUTICS, INC. | Director | $4,860,906 | 26 May 2023 | ||
| BIOS | BioPlus Acquisition Corp. | CEO and CFO, Director | 02 Dec 2021 | |||
| EPHY | Epiphany Technology Acquisition Corp. | Co-Chief Executive Officer, Director | 16 Sep 2022 |
Insider Transactions Reported by Ross Haghighat:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.